Accueil   Diary - News   All news New members - November

New members – November

Founded in 2017 and headquartered in Lyon, Meersens, a startup with strong social impact, is the first predictive and preventive AI solution with the goal to become the leader in Exposom’s data. We make visible the invisible in order to reduce potential environmental impacts on people’s health (Air, water, UV, noise, food…) and therefore, in a long term, having a better understanding of effects on human health. Our solutions are used in cohorts’ studies, within smart cities programs and in companies with strong Corporate & Social Responsibility programs to improve health and wellbeing of citizens / employees. Based on WHO’s standards and our expertise, Meersens deploy personalized solution to meet profiles, usages and various types of pathologies to limit/reduce identified risks. Relevant data are accessible through Meersens’ App to contribute to a healthier world.


See Meersens profil is a teleconsultation platform patient/doctor created, thought and financed by health professionals, capital of €205 800, based in Lyon. Multi-platform, the site requires no installation but only a browser. It allows to exchange in writing and video, to send documents text/picture/video, to create prescriptions and certificates. Finally, there is no additional software for the payment and remote transmission.

See profil


Vidium is the Google Map of gene networks.

The current techniques available to scientists only allow them to know whether or not they will be blocked further in the research. Vidium goes beyond that. With our executable genetic map, we guide researchers through cell complexity to control cell behavior in order to develop effective treatments and reduce R&D costs. Consequently, we help them to drastically reduce the duration and costs of research and, above all, to increase their chances of success.




Located in the heart of the “HA Valley”, in Annecy, Falgagen is a French company supporting the Life Science industry in the conception, development, and integration of medical devices comprising natural polymers, with a strong expertise in Hyaluronic Acid and Chitosan.

The team consists of scientists and medical device strategists, bringing a cumulated experience of 30 years, to provide industrial partners with customised projects with high quality services for boosting their competences and productivity, for building up new market opportunities and developing tomorrow’s products. 

Falgagen customised services comprises R&D activities (formulation conception, improvement), industrial operations (manufacturing plant set-up, process development, technology transfers, CMO qualification and execution, process optimisation), and business development (support to in- & out-licensing activities, due diligences), in several application areas: aesthetic dermatology, ophthalmology, orthopaedics and gynaecology.


See Falgagen profil